Losartan for Preventing Aortic Root Dilatation in Patients with Marfan Syndrome: A Meta-Analysis of Randomized Trials
ConclusionIn this meta-analysis including seven randomized trials, the use of losartan was associated with a significantly smaller change in aortic root diameter in patients with Marfan syndrome.
Source: Cardiology and Therapy - Category: Cardiology Source Type: research
More News: Beta-Blockers | Cardiology | Clinical Trials | Computers | Cozaar | Databases & Libraries | Heart | Losartan | Marfan Syndrome